Trademarks

AMZYART

Serial number
99872237
Registration number
Not registered
Filed
2026-06-08
Registered
Not registered
Status
Pending application (USPTO status code 680, 2026-10-19; as of the dataset)
Classes
005
Elsewhere
USPTO TSDR record (current status) ↗
Source
TRTDXFAP, file of 2026-10-20

Goods and services

Antivirals; Antibodies for medical purposes; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes; Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, autoimmune diseases, solid organ transplant rejection, autoinflammatory diseases, blood diseases, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, Alzheimer’s disease, autism spectrum disorder, and musculoskeletal and skin diseases; Biological preparations for the treatment of cancer

Owners

OwnerRoleEntityPlaceAlso on furp.orgSource
Celgene CorporationOriginal applicantCorporationPrinceton, NJTRTDXFAP, file of 2026-10-20

Assignment history

No recorded assignments on file for this mark.

USPTO bulk data: the Trademark Case Files Dataset (TRCFECO2; the latest release, March 2024, runs through 2023) for marks, owners, classes and goods and services; the Trademark Assignment Dataset (TRASECO) for assignments. Marks filed in the last 20 years, plus older marks still registered. Status here is read from the dataset’s dates and status code; TSDR has the current status. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.